MA33692B1 - Procédé de fabrication de composés organiques - Google Patents

Procédé de fabrication de composés organiques

Info

Publication number
MA33692B1
MA33692B1 MA34806A MA34806A MA33692B1 MA 33692 B1 MA33692 B1 MA 33692B1 MA 34806 A MA34806 A MA 34806A MA 34806 A MA34806 A MA 34806A MA 33692 B1 MA33692 B1 MA 33692B1
Authority
MA
Morocco
Prior art keywords
manufacturing
organic compounds
antagonist
receptor
angiotensin receptor
Prior art date
Application number
MA34806A
Other languages
Arabic (ar)
English (en)
Inventor
Gottfried Sedelmeier
Florian Andreas Rampf
Dominique Grimler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41716392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33692(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA33692B1 publication Critical patent/MA33692B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention porte sur des procédés de fabrication d'un bloqueur de récepteur de l'angiotensine (arb; également appelé antagoniste du récepteur il de l'angiotensine ou antagoniste du récepteur at1) et leurs sels, sur de nouveaux intermédiaires et étapes de procédé.
MA34806A 2009-10-27 2012-04-26 Procédé de fabrication de composés organiques MA33692B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09174264A EP2316821A1 (fr) 2009-10-27 2009-10-27 Procédé pour la fabrication de composés organiques
PCT/EP2010/066041 WO2011051213A1 (fr) 2009-10-27 2010-10-25 Procédé de fabrication de composés organiques

Publications (1)

Publication Number Publication Date
MA33692B1 true MA33692B1 (fr) 2012-10-01

Family

ID=41716392

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34806A MA33692B1 (fr) 2009-10-27 2012-04-26 Procédé de fabrication de composés organiques

Country Status (24)

Country Link
US (1) US20120238761A1 (fr)
EP (2) EP2316821A1 (fr)
JP (1) JP2013508436A (fr)
KR (1) KR20120098652A (fr)
CN (1) CN102596899A (fr)
AR (1) AR079104A1 (fr)
AU (1) AU2010311636B2 (fr)
BR (1) BR112012009815A2 (fr)
CA (1) CA2777031A1 (fr)
CL (1) CL2012001081A1 (fr)
CO (1) CO6531487A2 (fr)
EC (1) ECSP12011833A (fr)
IL (1) IL219111A0 (fr)
IN (1) IN2012DN03032A (fr)
MA (1) MA33692B1 (fr)
MX (1) MX2012005025A (fr)
NZ (1) NZ599218A (fr)
PE (1) PE20121501A1 (fr)
PH (1) PH12012500677A1 (fr)
RU (1) RU2012121591A (fr)
TN (1) TN2012000154A1 (fr)
TW (1) TW201124389A (fr)
WO (1) WO2011051213A1 (fr)
ZA (1) ZA201202490B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102321038B (zh) * 2011-07-11 2014-03-26 安徽省虹升生物科技有限公司 一种改进的制备缬沙坦方法
FR2981077B1 (fr) * 2011-10-11 2013-11-01 Michelin Soc Tech Methode pour preparer un melange maitre d'elastomere dienique et de silice
EP3508479A4 (fr) * 2016-09-02 2020-02-19 Noratech Pharmaceuticals, Inc. Formes cristallines de sel disodique de valsartan
CN110078640B (zh) * 2019-03-29 2022-04-05 浙江美诺华药物化学有限公司 一种缬沙坦中间体的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874867A (en) 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
EP0443983B1 (fr) 1990-02-19 1996-02-28 Ciba-Geigy Ag Composés acylés
JPH04297466A (ja) 1990-06-22 1992-10-21 Nippon Shinyaku Co Ltd テトラゾール誘導体及び医薬
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
GB0222056D0 (en) 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
ITMI20032267A1 (it) * 2003-11-21 2005-05-22 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procdimento per la preparzione di valsartan e suoi intermedi
HRP20030965A2 (en) * 2003-11-24 2005-08-31 Belupo - Lijekovi I Kozmetika D.D. Process for production of (s)-n-pentanoyl-n-[[2'-(
EP1714963A1 (fr) * 2005-04-19 2006-10-25 IPCA Laboratories Limited Procédé pour la préparation du Valsartan et de ses intermédiaires
DE602006008962D1 (de) * 2005-08-22 2010-07-08 Alembic Ltd Verfahren zur herstellung von valsartan
US7880015B2 (en) * 2006-07-03 2011-02-01 Aurobindo Pharma Ltd. Process for the preparation of angiotensin II antagonist
CN101450917B (zh) * 2007-12-06 2012-07-11 浙江海正药业股份有限公司 缬沙坦的合成方法
EP2090567A3 (fr) * 2008-02-13 2011-06-01 Ranbaxy Laboratories Limited Processus pour la préparation d'intermédiaires de valsartan

Also Published As

Publication number Publication date
MX2012005025A (es) 2012-06-08
IL219111A0 (en) 2012-06-28
IN2012DN03032A (fr) 2015-07-31
JP2013508436A (ja) 2013-03-07
EP2493848A1 (fr) 2012-09-05
AU2010311636A1 (en) 2012-05-03
CL2012001081A1 (es) 2013-06-14
PE20121501A1 (es) 2012-11-15
BR112012009815A2 (pt) 2016-10-18
KR20120098652A (ko) 2012-09-05
TN2012000154A1 (en) 2013-12-12
CA2777031A1 (fr) 2011-05-05
WO2011051213A1 (fr) 2011-05-05
EP2316821A1 (fr) 2011-05-04
AR079104A1 (es) 2011-12-28
ZA201202490B (en) 2012-12-27
US20120238761A1 (en) 2012-09-20
AU2010311636B2 (en) 2014-03-06
CO6531487A2 (es) 2012-09-28
RU2012121591A (ru) 2013-12-10
CN102596899A (zh) 2012-07-18
ECSP12011833A (es) 2012-06-29
NZ599218A (en) 2014-02-28
PH12012500677A1 (en) 2012-10-29
TW201124389A (en) 2011-07-16

Similar Documents

Publication Publication Date Title
CY1118332T1 (el) Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξamιδο-πυριδιno βενζοϊκων οξεων
BRPI0914092A2 (pt) método de produção de um anticorpo a partir de células plasmáticas, método de produção de um anticorpo monoclonal a partir de células plasmáticas, método de produção de um anticorpo ou de um fragmento de anticorpo, anticorpo isolado ou fragmento de anticorpo, anticorpo ou fragmento de anticorpo e composição farmacêutica
WO2010008847A3 (fr) Inhibiteurs de pi3k/m tor
EP2319963A4 (fr) Méthode de fabrication de monocristaux de carbure de silicium
MA34520B1 (fr) Anticorps se liant à la myostatine, compositions et procédés
EP2367931A4 (fr) Procédés de dérivation de cellules différenciées à partir de cellules souches
EA200800549A1 (ru) Региоселективный способ получения бензимидазолтиофенов
EA201100517A1 (ru) Способ получения дабигатрана и его промежуточные соединения
EP2508653A4 (fr) Procédé de fabrication d'un monocristal
EP2297033A4 (fr) Procédé pour la fabrication de carbure de silicium
EA201270212A1 (ru) Способ изготовления элемента, содержащего минеральное волокно, и элемент, изготовленный этим способом
EP2246353A4 (fr) Procédé de production d'un composé d'adénine
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
FR2935703B1 (fr) Procede de preparation de composes fluores.
EP2371830A4 (fr) Méthode de production d'un dérivé de diamine
EP2075312A4 (fr) Procédé de fabrication du nitrure ou oxonitrure
EP2336355A4 (fr) Procédé de prédiction de rythme biologique
EP1911733A4 (fr) Procédé de formation d'unités de maçonnerie
EP2371765A4 (fr) Procédé de fabrication d'un chlorosilane
EP2377841A4 (fr) Procédé de production d'un composé d'alcool
EP2310611A4 (fr) Procédé de détermination de zone morte de soupape
EP2256102A4 (fr) Procédé de fabrication d'un composé alcoxycarbonyle
EP2417268A4 (fr) Procédé de diagnostic utilisant palb2
EP2272954A4 (fr) Procédé de fabrication d'une enzyme immobilisée
TN2012000154A1 (en) Process for the manufacture of organic compounds